Concepedia

Author

Rosanne M. Orr

Institute of Cancer Research

Also Known As

Orr, R M Orr, R. Orr, R.M. ORR, R.M. Orr, RM Orr, Rosanne M Orr, Rosanne M. Orr

17

Publications

519

Citations

10

H-Index

41

Concepts

All Affiliations

Institute of Cancer Research
RM

About

Rosanne M. Orr is an author at Institute of Cancer Research specializing in medicine, cell biology, and pharmacology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

7

7

347

2

Cell Biology

4

4

112

3

Natural Sciences

3

3

61

4

Biochemistry

2

2

32

5

Immunology

2

2

108

Rosanne M. Orr

×

9

Publications

474

Citations

9

H-Index

YearCitations

Induction of apoptosis by a novel copper-based anticancer compound, Casiopeina II, in L1210 murine leukaemia and CH1 human ovarian carcinoma cells

Andrea De Vizcaya‐Ruíz, Adolfo Rivero‐Müller, George E.N. Kass,

Toxicology in Vitro

2000

133

Pharmacokinetics of G3139, a Phosphorothioate Oligodeoxynucleotide Antisense to bcl-2, after Intravenous Administration or Continuous Subcutaneous Infusion to Mice

Florence I. Raynaud, Rosanne M. Orr, Phyllis M. Goddard,

Journal of Pharmacology and Experimental Therapeutics

1997

107

Technology evaluation: fomivirsen, Isis Pharmaceuticals Inc/CIBA vision.

Rosanne M. Orr

PubMed

2001

89

Disruption of WT1 gene expression and exon 5 splicing following cytotoxic drug treatment: antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival.

Jane Renshaw, Rosanne M. Orr, Michael I. Walton,

PubMed

2004

32

Novel trans platinum complexes: comparative in vitro and in vivo activity against platinum-sensitive and resistant murine tumours.

Phyllis M. Goddard, Rosanne M. Orr, Melanie Valenti,

PubMed

1996

32

Disruption of <i>WT1</i> gene expression and exon 5 splicing following cytotoxic drug treatment: Antisense down-regulation of exon 5 alters target gene expression and inhibits cell survival

Jane Renshaw, Rosanne M. Orr, Michael I. Walton,

Molecular Cancer Therapeutics

2004

29

Platinum coordination complexes which circumvent cisplatin resistance

Ken R. Harrap, Lloyd R. Kelland, Mervyn Jones,

Advances in Enzyme Regulation

1991

20

2'-Deoxycytidine kinase deficiency is a major determinant of 2-chloro-2'-deoxyadenosine resistance in lymphoid cell lines

Rosanne M. Orr, Denis Talbot, G. Wynne Aherne,

PubMed

1995

19

Dinucleotide analogs as inhibitors of thymidine kinase, thymidylate kinase and ribonucleotide reductase

Lawrence Davies, J. A. Stock, S. Elaine Barrie,

Journal of Medicinal Chemistry

1988

13

Page 1